| Desitin Pharma GmbH - Apydan extent 150 mg, Tabletten |
| 57883 | | 01 | | Apydan extent 150 mg | | Tabletten | | N03AF02 | | Oxcarbazepine | | 10.11.2010 | | |
|
| Composition |
| oxcarbazepinum 150 mg, ammonio methacrylatis copolymerum B, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.08 mg, magnesii stearas, E 101 pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Oxcarbazepine | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Oxcarbazepine | 150 mg |
| | | | Inactive agents | | additional_information |
|---|
| Ammonio Methacrylatis Copolymerum B | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 101 | | color. | | Magnesii Stearas | | | | Pro Compresso | | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 50 Tablet(s) | 7.02 | 16.85 | B | SL | No |
|
